RECALIBRATE YOUR HEALTHCARE STRATEGY
Learn 4 strategic pivots for 2025 and beyond.
Learn more

Library

| Daily Briefing

Weekly review: These Covid-19 symptoms are likeliest to linger for 6 months—or more


What research says about whether vitamin D can prevent Covid-19, the Covid-19 symptoms likeliest to linger for at least six months, and more.

How much is asymptomatic spread driving Covid-19? Here's what the evidence says. (Monday, January 11)

A new CDC model sheds light on how many coronavirus cases are driven by people who exhibit no symptoms of Covid-19—and experts say the model's findings are even more concerning in light of the emergence of a new, more contagious variant of the virus.

These Covid-19 symptoms are likeliest to linger for 6 months—or more (Tuesday, January 12)

A significant majority of patients who've been hospitalized for Covid-19 still had at least one symptom of the disease six months after they'd recovered from their initial coronavirus infection, according to a first-of-its-kind study—and some long-term symptoms were more common than others.

How Marc D. Miller and his father built UHS—and where Marc's taking the $11.4B system next (Wednesday, January 13)

In this edition of "Lessons from the C-suite," Marc D. Miller, CEO and president of Universal Health Services, talks with Advisory Board President Eric Larsen and OptumInsight CEO Robert Musslewhite about succeeding his father at the helm of the $11.4 billion health care organization, delivering industry-leading health care outcomes while staying under the radar, providing "whole person" care before it was a buzzword, and more.

Can vitamin D really prevent Covid-19? Here's what the evidence says. (Thursday, January 14)

Vitamin D supplement sales have soared amid the pandemic based on early suggestions that it might help prevent Covid-19—but how strong is the evidence of the vitamin's benefits? Here's what we know so far.

Are two face masks better than one? Here's what researchers say. (Friday, January 15)

Many prominent people, from football coaches to senators, are "double-masking" in public in an effort to reduce their risk of coronavirus infection. But is this actually an effective tactic—and if so, what's the best way to do it? Here's what leading researchers told Katherine Wu of the New York Times.


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

INDUSTRY SECTORS

MORE FROM TODAY'S DAILY BRIEFING

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.